Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_assertion type Assertion NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_head.
- NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend the potential options for therapeutic targeting of kinases in the treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_provenance.
- NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_assertion evidence source_evidence_literature NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_provenance.
- NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_assertion SIO_000772 14507635 NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_provenance.
- NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_assertion wasDerivedFrom befree-20140225 NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_provenance.
- NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_assertion wasGeneratedBy ECO_0000203 NP743085.RAEJ1y79uUCpSzYofU2UNhJJ_HmXfRgvoeVjwIAy5S-A0130_provenance.